Atlanta-based Institut’ DERMed Clinical Skincare have launched their innovative product line comprising of an advanced anti-aging serum. The Anti- Oxidant Peptide Serum is formulated with Pro-Coll-One Peptides and Apple Stem Cells. The company claims that this product is capable of increasing epidermal hydration while accelerating new cell growth and reducing skin stress and potential complications from environmental conditions.
Derived from soya, Pro-Coll-One Peptides contain highly purified glycopeptides which boost production of collagen. Studies have shown a consolidation of the dermal mattress significantly reduce wrinkles and smooth the skin’s surface. While the Apple Stem cells, derived from the UTTwiler Spatlauber is the first plant stem cell active ingredient on the market whose effect has been evaluated on human skin stem cells.
“Clinical trials with Uttwiler Spatlauber stem cells showed a significant reduction in wrinkle depth after two to four weeks. I’m extremely excited to be adding these ingredients to the Institut’ DERMed anti-aging product arsenal.” said Lyn Ross, Founder of Institut’ DERMed.